@Bjornformatics Profile picture

Bjørn Kwee

@Bjornformatics

PhD student @Schumacher_Lab @NKI_nl | Bioinformatics | Cancer Immunology | High-Performance Computing

Similar User
AI for Oncology Lab photo

@AI4Oncology

Cassian Yee photo

@tcellsrus

Ton Schumacher Lab photo

@Schumacher_lab

Dr Chris Thorpe photo

@drchristhorpe

NicklectedTropicalDiseases photo

@NickdeVrij

David Gfeller photo

@GfellerD

Pieter Meysman photo

@chevaliersf

Jonas Teuwen photo

@jonasteuwen

Jani Huuhtanen photo

@jhuuhtan

Benoit Nicolet photo

@BenNicolet

Roberta Zappasodi photo

@RZappasodi

Poor Man's ab lab photo

@theamsoon_lab

Joris van de Haar photo

@Joris_vd_Haar

Pengfei Zhang photo

@Pengfei17365177

vincentvB photo

@BVincentv

Pinned

Preprint alert 🚨🚨 Large language models can predict TCR - pMHC reactivity!🧬🔬 Proud to have worked on this project with @MariusMessemak1 and all other amazing co-authors.

Excited to share STAPLER, a language model to predict TCR – pMHC reactivity that outperforms prior models. And for ML aficionados: Description of a new data leakage problem inherent to a common negative data generation strategy. biorxiv.org/content/10.110… 🧵👇



Bjørn Kwee Reposted

Congratulations David Baker (@UW, member of #CancerGrandChallenges team MATCHMAKERS), who's won the 2024 Nobel Prize in Chemistry for his pioneering work building new kinds of proteins! 👏 More about MATCHMAKERS, funded by @CR_UK @theNCI @TheMarkFdn 👉 cancergrandchallenges.org/matchmakers

It's not easy to get hold of a newly awarded Nobel Prize laureate! We are happy that chemistry laureate David Baker took our call, as he turned down "100 calls" while he was on the phone with us. Hold tight for our upcoming interview with Baker.

Tweet Image 1


Bjørn Kwee Reposted

Ton Schumacher is closing #CancerHostTI24 discussing neoantigens and neoadjuvant therapy. With his research group he created technologies to dissect T cell responses in cancer and contributed to the development of adoptive T cell therapies and neoadjuvant cancer immunotherapy.

Tweet Image 1

Bjørn Kwee Reposted

Researchers from the group of @HaanenJohn and @Schumacher_lab have successfully developed a novel method that enables the identification of T cell receptors at an unprecedented scale ➡️ bit.ly/3Ql6ObG

Tweet Image 1

Bjørn Kwee Reposted

We’re excited to reveal that Team MATCHMAKERS has been selected by @CancerGrand to receive up to $25m over five years to take on one of cancer’s toughest challenges. Congratulations to Ton Schumacher @schumacher_lab and all the #CancerGrandChallenges teams!

Tweet Image 1

Bjørn Kwee Reposted

Excited to share STAPLER, a language model to predict TCR – pMHC reactivity that outperforms prior models. And for ML aficionados: Description of a new data leakage problem inherent to a common negative data generation strategy. biorxiv.org/content/10.110… 🧵👇


Bjørn Kwee Reposted

Follow our cancer immunology colleagues @NKI_nl

Hello world! The Schumacher lab is now also on Twitter!😃🔬



Bjørn Kwee Reposted

Woohoo 🙌🙌🙌! If you’re into immunology and immunotherapy, then you must know Ton Schumacher! Follow the lab’s new twitter account! @NKI_nl

Hello world! The Schumacher lab is now also on Twitter!😃🔬



Follow the Schumacher lab! (Exciting stuff coming up)

Hello world! The Schumacher lab is now also on Twitter!😃🔬



Bjørn Kwee Reposted

Impossible immunotherapy responses? It's the gamma delta's bro! Thrilled to see our work on γδ T cells and "impossible" immunotherapy responses of B2M mutant cancers in @Nature 🧵 below 👇👇👇

Tweet Image 1

Bjørn Kwee Reposted

Identification of patient-specific CD4⁺ and CD8⁺ T cell neoantigens through HLA-unbiased genetic screens go.nature.com/3Ida0mm

Tweet Image 1

Bjørn Kwee Reposted

Gene function is associated with distinct mRNA – protein levels. We show that mRNA, protein, and mRNA-protein levels are associated with sequence characteristics in human CD8+ T cells. In the lab of @WolkersMonika at @sanquin You can read more here: dx.plos.org/10.1371/journa…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.